How to treat small cell carcinoma of the lung better? Small cell carcinoma of the lung

Small cell lung cancer accounts for about 20 of lung cancers, is the most malignant lung cancer, cancer cells can double in about a month, if not, the average survival time of patients since diagnosis is less than 3 months, and the two-year survival rate is less than 1. The prognosis is extremely poor. Small cell lung cancer is sensitive to chemotherapy and radiotherapy, and chemotherapy and radiotherapy are the main regimens.

According to the progression of the disease and the clinical needs, small cell lung cancer can be divided into two types: limited stage and extensive stage. In the former, the lesion was confined to the affected lobe, and only regional lymph node metastasis; The latter involves the entire lungs, or extrathoracic metastases such as brain and bones. Small cell lung cancer (SCCLC) is a systemic disease that often spreads and metastasizes at an early stage, and about 70 to 90 patients are already in the extensive stage when diagnosed.

Chemotherapy is the most predominant form of small cell lung cancer**. Chemotherapy supplemented with necessary radiotherapy can prolong life in extensive-stage patients, but in almost all cases**, the average survival is 8 to 10 months. The norm for limited-stage small cell lung cancer is chemotherapy and radiotherapy.

That is, 2 3 cycles of chemotherapy are followed by local radiotherapy, followed by 2 3 cycles of chemotherapy. In general, 4 to 6 cycles of chemotherapy are more appropriate, too much chemotherapy will not increase the efficacy, but will significantly increase the toxicity***. For patients with localized small cell lung cancer who only have a solitary cancer tumor and no local spread or metastasis, chemotherapy can be given first, and then a comprehensive examination, if the cancer shrinks and has not yet spread or metastasized, it can be surgically resected, then chemotherapy, and prophylactic radiotherapy to the head to avoid the brain metastasis that is most likely to occur in small cell lung cancer.

Therefore, surgery is generally not preferred.

Hello! The main treatment of small cell lung cancer is chemotherapy + radiotherapy, a small number of patients can be operated, this patient's current condition is definitely not operable, and the combined pleural effusion is not suitable for radiotherapy temporarily. It is recommended to continue chemotherapy, the regimen can be used cisplatin + VP-16, repeat the CT before medication once in 3 weeks to see if it is effective, continue to use it if it has a dull wax effect, and change the dressing if it is ineffective.

Hood plexus chemotherapy reactions can be controlled with drugs, and leukocyte-raising drugs are continued between chemotherapy periods. Anhui Provincial Cancer Hospital should be a better hospital in the local area, and it is recommended to go to the Department of Medical Oncology or Radiotherapy.

The average smoker is susceptible to small cell lung cancer. The disease progresses particularly rapidly. Generally, patients are basically at an advanced stage as soon as they arrive at the hospital.

Small cell patients do not have surgery. Although the disease is urgent and severe, as long as you go to the hospital for chemotherapy and other methods, you can effectively inhibit the development of the disease, and this disease is very sensitive to radiotherapy and chemotherapy. Effectively prolongs survival.

In this regard, there is no possibility of being able to completely do it in medicine. Hope it helps. If there is really a patient with this disease around him, advise him not to delay.

To do it as soon as possible**. Hope it helps.

This is a classification of lung cancer, and it is still difficult to rely on chemotherapy, but it is necessary to adhere to it.

Most of the patients with early stage of small cell lung cancer can be **, and some of the locally advanced ones can also be **, and it is difficult for patients with advanced stage to achieve **. The vast majority of patients with early stage of small cell lung cancer can be treated with surgery, and some of them are locally advanced patients, given local radiotherapy plus chemotherapy, and some of them can be achieved, so advanced patients, patients who have had distant metastases, the vast majority of patients, with our existing means, it is still difficult to achieve, we mainly improve their quality of life, prolong survival, of course, we now have, immunity and targeting, this part of the patients have survival time, There has been a significant extension, such as the Oak pathway, this pathway has mutated patients, also called diamond mutations, its average survival has reached nearly 8 years, immunity ** Similarly, if the patient's immunity ** is effective, he also has a long survival time, in general, a survival of the patient ** is related to his stage, that is, the earlier the better, which is why we advocate lung cancer to, early detection, early diagnosis, early **.